Nitric Oxide, Aspirin-Triggered Lipoxins and NO-Aspirin in Gastric Protection

Publisher： Bentham Science Publishers

E-ISSN： 2212-4055|5|2|133-137

ISSN： 1871-5281

Source： Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol.5, Iss.2, 2006-04, pp. : 133-137

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lipid Mediators: Lipoxin and Aspirin-Triggered 15-Epi-Lipoxins

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 5, Iss. 2, 2006-04 ,pp. : 81-90

Bentham Science Publishers

Access to resources Recommend Favorite

Lipoxins, The Novel Mediators of Gastroprotection and Gastric Adaptation to Ulcerogenic action of Aspirin

By  

Current Pharmaceutical Design, Vol. 17, Iss. 16, 2011-06 ,pp. : 1541-1551

Bentham Science Publishers

Access to resources Recommend Favorite

Effect of dipyridamole and aspirin on the platelet-neutrophil interaction via the nitric oxide pathway

By De La Cruz J.P.   Blanco E.   Sanchez de la Cuesta F.  

European Journal of Pharmacology, Vol. 397, Iss. 1, 2000-05 ,pp. : 35-41

Elsevier

Access to resources Recommend Favorite

Prevention of pulmonary thromboembolism by NCX 4016, a nitric oxide-releasing aspirin

By Momi S.   Emerson M.   Paul W.   Leone M.   Mezzasoma A.M.   Del Soldato P.   Page C.P.   Gresele P.  

European Journal of Pharmacology, Vol. 397, Iss. 1, 2000-05 ,pp. : 177-185

Elsevier

Access to resources Recommend Favorite

Nitric oxide-donating non-steroidal anti-inflammatory drugs: the case of nitroderivatives of aspirin

By Chiroli V.   Benedini F.   Ongini E.   Del Soldato P.  

European Journal of Medicinal Chemistry, Vol. 38, Iss. 4, 2003-04 ,pp. : 441-446

Elsevier

Access to resources Recommend Favorite